Document is current
Any future updates will be listed below
-
Authors
Liston, Theodore E.
Korinek, William S.
Jacobson, Kenneth A.
Lechleiter, James D.
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R44NS102398)
National Institute of Neurological Disorders and Stroke (R41NS094327)
Medical Technology Enterprise Consortium (W81XWH-21-9-0001)
National Institute of Diabetes and Digestive and Kidney Diseases (ZIADK031117)
- License Information
-
More Information
Article History
Received: 18 April 2026
Accepted: 5 May 2026
First Online: 12 May 2026
Declarations
:
: All in vivo preclinical studies described in this article were conducted following review and approval by relevant IACUC committees. All clinical studies described were conducted in accordance with applicable regulatory requirements and were reviewed and approved by the relevant national regulatory authorities and independent ethics committees.
: TEL and WSK are employees of Astrocyte Pharmaceuticals Inc. with multiple patents. JDL is a cofounder of Astrocyte Pharmaceuticals Inc. with multiple patents.
